Who
Mazin Sabra
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, ClearPoint Neuro.
In numbers
- Trades disclosed
- 44
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Oct 2022
- Last trade
- 12 Mar 2026
- Last filed
- 16 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Mar 2026filed 16 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —26,101 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code F | $153K13,281 at $11.53 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —26,101 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —26,101 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —26,101 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code F | $153K13,281 at $11.53 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —13,827 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code F | $70K7,036 at $10.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —13,827 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —13,827 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —13,827 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code F | $70K7,036 at $10.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —6,642 | filing |
| 3 Mar 2026filed 5 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code F | $30K3,380 at $8.84 | filing |
| 3 Mar 2026filed 5 Mar 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —6,642 | filing |
| 3 Mar 2026filed 5 Mar 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —6,642 | filing |
| 3 Mar 2026filed 5 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —6,642 | filing |
| 3 Mar 2026filed 5 Mar 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code F | $30K3,380 at $8.84 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —36,818 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —36,818 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.